TLR4 and neoplasm: Colorectal cancer was induced in male BALB/c mice and then was treated with a 30 mg/kg/day oral dose of RA for a week, and it was found to suppress tumor progression in mice through the inhibition of TLR4-mediated NF-κB and STAT3 activation.